$6.470
0.000 (0.00%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
該買進 Sinovac Biotech Ltd 股票嗎？
Sinovac Biotech Ltd is currently not a strong buy due to its negative financial metrics, including a forward P/E ratio of 357.14, indicating high valuation concerns. While the company has declared a special cash dividend of $55 per share, which could enhance shareholder confidence, the overall financial performance shows significant risks, particularly with a negative price-to-earnings ratio of -1.87. The main risk is the high forward P/E ratio, suggesting that the stock may be overvalued at its current price.
SVA 股價於 Friday 收在 $6.47，此前上漲 0.00%
Sinovac Biotech Ltd (SVA) last closed at $6.47, gaining +0.00%. These facts feed the 1-day and 1-week SVA price prediction above.
預測驅動因素
Sinovac Biotech Ltd（SVA）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
SVA 季節性分析
Historically the probability of a positive September return for SVA is 0.00%. January offers the highest probability of a positive month at 0.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。